These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32200330)
1. Potent colchicine-site ligands with improved intrinsic solubility by replacement of the 3,4,5-trimethoxyphenyl ring with a 2-methylsulfanyl-6-methoxypyridine ring. Álvarez R; Aramburu L; Gajate C; Vicente-Blázquez A; Mollinedo F; Medarde M; Peláez R Bioorg Chem; 2020 May; 98():103755. PubMed ID: 32200330 [TBL] [Abstract][Full Text] [Related]
2. Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents. Álvarez R; Aramburu L; Gajate C; Vicente-Blázquez A; Mollinedo F; Medarde M; Peláez R Eur J Med Chem; 2021 Jan; 209():112933. PubMed ID: 33328100 [TBL] [Abstract][Full Text] [Related]
3. Novel amino analogs of the trimethoxyphenyl ring in potent colchicine site ligands improve solubility by the masked polar group incorporation (MPGI) strategy. González M; Ellahioui Y; Gallego L; Vicente-Blázquez A; Álvarez R; Medarde M; Peláez R Bioorg Chem; 2023 Feb; 131():106282. PubMed ID: 36459777 [TBL] [Abstract][Full Text] [Related]
4. Exploring the size adaptability of the B ring binding zone of the colchicine site of tubulin with para-nitrogen substituted isocombretastatins. Jiménez C; Ellahioui Y; Álvarez R; Aramburu L; Riesco A; González M; Vicente A; Dahdouh A; Ibn Mansour A; Jiménez C; Martín D; Sarmiento RG; Medarde M; Caballero E; Peláez R Eur J Med Chem; 2015 Jul; 100():210-22. PubMed ID: 26092446 [TBL] [Abstract][Full Text] [Related]
5. The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors. González M; Ellahioui Y; Álvarez R; Gallego-Yerga L; Caballero E; Vicente-Blázquez A; Ramudo L; Marín M; Sanz C; Medarde M; Pelaéz R Molecules; 2019 Nov; 24(23):. PubMed ID: 31779228 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors. Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816 [TBL] [Abstract][Full Text] [Related]
7. A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents. Romagnoli R; Oliva P; Salvador MK; Manfredini S; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Rruga F; Mariotto E; Viola G; Bortolozzi R Eur J Med Chem; 2021 Mar; 214():113229. PubMed ID: 33550186 [TBL] [Abstract][Full Text] [Related]
8. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo. Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012 [TBL] [Abstract][Full Text] [Related]
9. New Combretastatin Analogs as Anticancer Agents: Design, Synthesis, Microtubules Polymerization Inhibition, and Molecular Docking Studies. Abdul Hussein SA; Razzak Mahmood AA; Tahtamouni LH; Balakit AA; Yaseen YS; Al-Hasani RA Chem Biodivers; 2023 Apr; 20(4):e202201206. PubMed ID: 36890635 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxic evaluation and molecular docking study of 2-alkylthio-4-(2,3,4-trimethoxyphenyl)-5-aryl-thiazoles as tubulin polymerization inhibitors. Salehi M; Amini M; Ostad SN; Riazi GH; Assadieskandar A; Shafiei B; Shafiee A Bioorg Med Chem; 2013 Dec; 21(24):7648-54. PubMed ID: 24238904 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and bioevaluation of N-(3,4,5-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-amines as tubulin polymerization inhibitors with anti-angiogenic effects. Hao SY; Qi ZY; Wang S; Wang XR; Chen SW Bioorg Med Chem; 2021 Feb; 31():115985. PubMed ID: 33421913 [TBL] [Abstract][Full Text] [Related]
12. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance. Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817 [TBL] [Abstract][Full Text] [Related]
13. Substitution at the indole 3 position yields highly potent indolecombretastatins against human tumor cells. Álvarez R; Gajate C; Puebla P; Mollinedo F; Medarde M; Peláez R Eur J Med Chem; 2018 Oct; 158():167-183. PubMed ID: 30216850 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
15. N-aryl-6-methoxy-1,2,3,4-tetrahydroquinolines: a novel class of antitumor agents targeting the colchicine site on tubulin. Wang XF; Wang SB; Ohkoshi E; Wang LT; Hamel E; Qian K; Morris-Natschke SL; Lee KH; Xie L Eur J Med Chem; 2013 Sep; 67():196-207. PubMed ID: 23867604 [TBL] [Abstract][Full Text] [Related]
16. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors. Yang F; He CP; Diao PC; Hong KH; Rao JJ; Zhao PL Bioorg Med Chem Lett; 2019 Jan; 29(1):22-27. PubMed ID: 30448234 [TBL] [Abstract][Full Text] [Related]
17. Effects on tubulin polymerization and down-regulation of c-Myc, hTERT and VEGF genes by colchicine haloacetyl and haloaroyl derivatives. Marzo-Mas A; Falomir E; Murga J; Carda M; Marco JA Eur J Med Chem; 2018 Apr; 150():591-600. PubMed ID: 29550732 [TBL] [Abstract][Full Text] [Related]
18. New thiazole-2(3H)-thiones containing 4-(3,4,5-trimethoxyphenyl) moiety as anticancer agents. Ansari M; Shokrzadeh M; Karima S; Rajaei S; Fallah M; Ghassemi-Barghi N; Ghasemian M; Emami S Eur J Med Chem; 2020 Jan; 185():111784. PubMed ID: 31669850 [TBL] [Abstract][Full Text] [Related]
19. New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure-activity relationships, and molecular modelling. Vicente-Blázquez A; González M; Medarde M; Mollinedo F; Peláez R J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2025-2044. PubMed ID: 34514909 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel pyrazolo[3,4-b]pyridines as cis-restricted combretastatin A-4 analogues. Jian XE; Yang F; Jiang CS; You WW; Zhao PL Bioorg Med Chem Lett; 2020 Apr; 30(8):127025. PubMed ID: 32063430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]